Quick search:
Content Ideas
Result | Content Idea | Research |
---|---|---|
Result | Content Idea | Research |
1 | Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) |
|
2 | FDA Grants Priority Review for Retifanlimab for Advanced Squamous Cell Carcinoma of the Anal Canal |
|
3 | Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA |
|
4 | Bla bla bla for biodiversity |
|
5 | Provention Bio Announces US FDA Filing of a Biologics License Application (BLA) and Priority Review for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals |
|
6 | Manufacturers submit rolling BLA to FDA for CAR-T to treat advanced multiple myeloma |
|
7 | Biologics License Application for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA |
|
8 | FDA Accepts BLA for Pediatric GHD Drug |
|
9 | FDA Defers Action on BLA for Bevacizumab Biosimilar MYL-1402O |
|
10 | FDA Defers BLA Action of Bevacizumab Biosimilar Due to COVID-19 Restrictions |
|
11 | Pfizer's (PFE) BLA for Somatrogon Gets FDA's Acceptance |
|
12 | POTD: A comical corgi bloodbath and a miracle gas blast escape |
|
13 | Bla Bla Beach Club to open this week |
|
14 | Transportation Aggregators Market 2021-2028 Culminated to Grow High by profiling companies: Uber Technologies,ANI Technologies,Lyft,Gett,Shippr,Grab Holdings,Bla Bla,Fehr&Peers,BlackBuck |
|
15 | Merck : FDA Accepts For Priority Review BLA For Adult Invasive Pneumococcal Vaccine |
|
16 | Humanigen Announces the Addition of BARDA and Expansion of CRADA with the US Government to Develop Lenzilumab for COVID-19 |
|
17 | RAY FISHER'S "BLA-BLA-BLA" CONTINUES, MAKING NO SENSE |
|
18 | Bla Bla: JBR's huge new beach club is set to open this Thursday |
|
19 | Atara Biotherapeutics Provides Regulatory Update for Tab-Cel® for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease |
|
20 | More than 50 countries commit to protecting 30% of Earth’s land and oceans |
|
21 | FDA Grants Priority Review to Treatment for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy |
|
22 | USFDA defers action on BLA for Avastin biosimilar, notifies Biocon Biologics, Mylan |
|
23 | New Orange & Purple Book laws increase transparency of patent information for drugs, biologics |
|
24 | Balochistan: BLA claimed to have killed 11 Pakistani troops in Sibbi |
|
25 | One Planet Summit: no climate fix without biodiversity |
|
26 | Court points out 5 BLA members in Chinese consulate attack case |
|
27 | Mariel Padilla shuns rumor linking husband Robin to Mocha Uson |
|
28 | Sesen Bio, Inc. 8-K Jan. 19, 2021 8:00 AM |
|
29 | BLA attacks Pak Army post in Bolan, kills 11 personnel |
|
30 | ATC indicts five BLA members in Chinese consulate attack case |
|
31 | ATC declares 15 BLA members absconders in 2018 Chinese consulate attack |
|
32 | As 19th Century Females, Sisters In 'The Doctors Blackwell' Achieve Many Firsts |
|
33 | Legislative Changes to FDA’s Orange Book and Purple Book Listing Requirements |
|
34 | Biocon shares fall as generic sales disappoint |
|
35 | Omar Kakroo to be Continued as President Municipal council Bla as per J&K High court order |
|
36 | Alandia and Blå Mediamentor team up to support mental health among seafarers |
|
37 | Turner says future vaccine megasites are dependent on supply |
|
38 | Narsoplimab Under Review for Stem Cell Transplant-Associated Thrombotic Microangiopathy |
|
39 | How Warnock and Ossoff's victories evoked the history of the Black freedom struggle |
|
40 | Remembering Eric Jerome Dickey |
|
41 | Hanmi Pharmaceutical expects US FDA approval for 2 new drugs |
|
42 | An intimate gaze: Ruth Motau on documenting life in black and white |
|
43 | Transportation Aggregators Market Dynamics, Target Audience, Forecast by Manufacturers – Beijing Xiaoju Keji Co., Ltd. (Didi Dache), Bla Bla Car, RideScout, Ola, Fehr&Peers, Uber Technologies Inc. (Uber), Vaahika, Aritron, GrabTaxi Pte Ltd Block (Grab Taxi), Gett, Meru, ANI Technologies Pvt. Ltd. (Ola Cabs), Lyft Inc |
|
44 | 'A Ghastly Future'? Israeli Apartheid, Biden, Starmer, Assange And Mass Extinction |
|
45 | Black Lives Matter calls convicted cop killer 'a political prisoner' |
|
46 | GDC Bla organises Talk on ‘Establishment of Road Safety Clubs’ |
|
47 | 9 fabulous things to do in Dubai this weekend |
|
48 | 2 militants killed in Wanigam Bla encounter |
|
49 | ONCOSEC MEDICAL INCORPORATED (NASDAQ:ONCS) Files An 8-K Entry into a Material Definitive Agreement |
|
50 | Bla gunfight: One militant killed, operation on |
|
51 | DC Bla reviews Covid-19 Vaccination arrangements |
|
52 | Karyl Seaman Stewart Obituary |
|
53 | GDC Bla, Organises Webinar on 'Structure Based Drug Design, Methods, Protocol |
|
54 | Aug 15 2022: PM sets as deadline for U'pur-Bla Rail Link project |
|
55 | Shipping majors trying to hit back – too late and too childish |
|
56 | Year Ender Report: Udhampur-Bla rail link to be completed by Dec 2022 |
|
57 | Gig Economy in Insurance Market Outlook 2021-2027, In-depth Analysis of Global Industry Growth, Share, Size and Future Demand by Key Players- Aribnb, Bizzby, Bla Bla Car, Click Worker, City Sprint, Deliveroo, Dinghy, eBay, Fantastic Handyman |
|
58 | PFT’s NFL 2020 conference championship game picks |
|
59 | Completion of Balstilimab BLA Filing Extended To 1H2021 |
|
60 | Janssen Files Rolling BLA Submission for on Cilta-Cel in R/R Multiple Myeloma |
|
61 | In Dubai, businesses are being creative with 'multi-functional' spaces |
|
62 | Push for Public BLA Talks Fail to Sway Council Majority |
|
63 | Agenus Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer |
|
64 | DBV Technologies gains 28% on FDA response regarding Viaskin Peanut application |
|
65 | Liminal BioSciences Announces FDA Extension of Review Period for Ryplazim®(plasminogen) BLA |
|
66 | FDA Will Not Complete Review of BLA for Lisocabtagene Maraleucel By PDUFA Date |
|
67 | Jazz (JAZZ) Initiates BLA Submission for Leukemia Candidate |
|
68 | Amicus (FOLD) Initiates Rolling BLA Submission for AT-GAA |
|
69 | Provention Bio Completes Rolling Submission of the Biologics License Application (BLA) for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals |
|
70 | FDA Accepts BLA for Biogen's Alzheimer's Drug, Grants Priority Review |
|
71 | Pandemic travel restrictions force FDA to delay a BLA review — involving a site inspection in Korea |
|
72 | ADC Inaugurates 2nd District Taekwondo Championship in Bla |
|
73 | FDA Accepts Biogen's BLA for Alzheimer's Candidate Aducanumab |
|
74 | CytoDyn Completed Submission of All Remaining Parts of Biologics License Application (“BLA”) on May 11, 2020 |
|
75 | FDA Accepts BLA for bluebird and BMS' Multiple Myeloma CAR-T Treatment |
|
76 | Technical Considerations for Demonstrating Reliability of Emergency-Use Injectors Submitted under a BLA, NDA or ANDA |
|
77 | Omeros Schedules Webcast to Present Final Efficacy Results from Narsoplimab BLA for the Treatment of HSCT-TMA |
|
78 | Janssen Submits BLA for Amivantamab to Treat Metastatic NSCLC with EGFR Exon 20 Insertion Mutations |
|
79 | Health Canada Clears CytoDyn to File its BLA for Leronlimab as One Injection per Week for Combination HIV Therapy |
|
80 | Teplizumab BLA for T1D Prevention Submitted |
|
81 | Special Meeting on Leesburg BLA Adjourns Without Town Council Quorum |
|
82 | U.K. MHRA Clears CytoDyn to File its BLA for Leronlimab as One Injection per Week for Combination HIV Therapy |
|
83 | J&J (JNJ) Begins Rolling BLA Filing of Multiple Myeloma Drug |
|
84 | Gamida Cell Provides Regulatory Update on Biologics License Application for Omidubicel |
|
85 | Ascendis Pharma A/S Announces U.S. Food and Drug Administration (FDA) Accepts Biologics License Application (BLA) for TransCon™ hGH for Pediatric Growth Hormone Deficiency (GHD) |
|
86 | Ascendis Pharma A/S Announces Submission of Biologics License Application (BLA) to FDA for TransCon™ hGH in Pediatric Growth Hormone Deficiency |
|
87 | Revance's (RVNC) DaxibotulinumtoxinA BLA Decision Delayed |
|
88 | CytoDyn Files Request With FDA for Priority Review of BLA for First Approval |
|
89 | TG Therapeutics Initiates BLA for Ublituximab Combo to Treat CLL |
|
90 | FDA Review of BLA for Liso-Cel in Relapsed/Refractory Large B-Cell Lymphoma Delayed by COVID-19 |
|
91 | BMS' CAR T cell therapy BLA accepted for priority review |
|
92 | DBV Technologies Receives Complete Response Letter from FDA for Viaskin Peanut BLA in Children Ages 4-11 Years |
|
93 | Bluebird: delays push sickle cell therapy BLA back |
|
94 | Bristol Myers Squibb Provides Update on Biologics License Application (BLA) for Lisocabtagene Maraleucel (liso-cel) |
|
95 | Update on HIV-BLA-PDUFA: FDA requested more information to complete a substantive review. No additional trials required. CytoDyn plans to submit the requested information and will ask for a Type A meeting with the FDA per the agency's suggestion |
|
96 | Pogba pledges Man United loyalty after Raiola comments |
|
97 | Sesen Bio Reports Third Quarter 2020 Financial Results and Positive Progress Towards Completing the BLA Submission for VicineumTM in December 2020 |
|
98 | FDA Receives BLA for Lonca in Relapsed/Refractory Diffuse Large B-cell Lymphoma |
|
99 | CytoDyn Receives BLA Acknowledgment Letter From the FDA |
|
100 | Iovance Biotherapeutics Provides Update for Lifileucel in Metastatic Melanoma |
|